The Pharma Data

AUGUST 11, 2020

It has not received general approval to treat the virus in the US, but has in several European countries and Japan. The request for approval comes nearly two months after a study from the National Institute of Allergy and Infectious Diseases which showed positive results, with the drug effectively blocking the virus from replicating.

FDA Approval 52

FDA Approval FDA Government Virus 52

The Pharma Data

AUGUST 19, 2020

Coronavirus tests are to be carried out on more people in the government’s monitoring programme to get a better idea of the spread of the virus. That means it can provide estimates for the true spread of the virus. Image copyright. Getty Images. For the survey, a representative sample of the general population is tested.

Virus 52

Virus Government Science Disease 52

Drug Target Review

SEPTEMBER 28, 2023

They needed reference materials for the disease in order to develop and validate diagnostic tests. For security reasons, at the time COVID-19 had to be grown in BSL-3 labs, which can be dangerous because they were handling the live virus. These are synthetic, not the live virus, so do not pose a risk of infection.

DNA 116

DNA Organic Chemistry Science Virus 116

Broad Institute

SEPTEMBER 30, 2024

Today, about a third of Broad’s Terra users are from the public health workforce; in the US, 76 state and local public health labs use the platform for preventing and monitoring infectious disease spread in their communities. This was true in the US and all the more in the Global South, where the burden of infectious disease is the highest.

Bioinformatics 101

Bioinformatics Disease Engineering Virus 101

Codon

OCTOBER 13, 2024

Through genetic engineering, researchers have developed Golden Rice which can help address the problem of vitamin A deficiency , cotton that produces its own insecticide , virus-resistant papayas , and more. One of these is “citrus canker,” a bacterial disease that causes the fruits to develop necrotic lesions.

Engineering 101

Engineering Virus Production DNA 101

The Pharma Data

DECEMBER 21, 2020

(Nasdaq:BCRX) today announced that data from part 1 of a clinical trial of its broad-spectrum antiviral, galidesivir, showed that galidesivir was safe and generally well tolerated in patients infected with SARS-CoV-2, the virus that causes COVID-19. It is in advanced development for the treatment of Marburg virus disease.

Clinical Trials 52

Clinical Trials Virus RNA Trials 52

The Pharma Data

OCTOBER 28, 2020

In the overall patient group with detectable virus at baseline, the average daily reduction in viral load through day 7 was a 0.36 About REGN-COV2 REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19.

Virus 40

Virus Trials Clinical Trials Production 40

The Pharma Data

JUNE 25, 2021

Nasdaq: NVAX), today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% Government.” 100) against moderate or severe disease. Variant Virus Strains. Novavax, Inc. variant, first identified in the U.K.,

Vaccine 40

Vaccine Trials Disease Immune Response 40

The Pharma Data

FEBRUARY 24, 2022

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) today announced that Health Canada has granted approval for COVIFENZ®, COVID-19 vaccine, (plant-based virus-like particles [VLP], recombinant, adjuvanted). This vaccine is indicated for active immunization to prevent coronavirus disease 2019 (COVID?19)

Vaccine 52

Vaccine Virus Government Disease 52

The Pharma Data

SEPTEMBER 25, 2020

Early tests showed the jab, developed by US biotechnology company Novavax, leads to high levels of virus-fighting antibodies being produced. The UK government has already ordered 60 million doses in case it proves successful. A trial of a new vaccine that appears to train the immune system to fight coronavirus has begun in the UK.

Vaccine 52

Vaccine Trials Immune Response Virus 52

The Pharma Data

DECEMBER 30, 2020

The Company aims to supply millions of doses in the first quarter as part of an agreement with the government to supply up to 100 million doses in total. We would like to thank our many colleagues at AstraZeneca, Oxford University, the UK government and the tens of thousands of clinical trial participants.”.

Vaccine 52

Vaccine Clinical Trials Trials Virus 52

The Pharma Data

AUGUST 7, 2020

The governing body claims this proposal could have positive effects on mitigating burdensome requirements for gene therapy clinical trials in the future. The ARM report also showcased robust pipelines of therapies targeting indications in cancers, infectious diseases and inherited disorders. Dr. Francis S.

Clinical Trials 52

Clinical Trials Trials Packaging Therapies 52

The Pharma Data

SEPTEMBER 4, 2020

The researchers vaccinated the hamsters and then exposed them to the virus a month later. These types of hamsters were chosen because they are more susceptible to contracting diseases than monkeys. Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters. Conor Kavanagh.

Vaccine 52

Vaccine Trials Virus Government 52

The Pharma Data

OCTOBER 6, 2021

A booster dose of the vaccine elicited significantly higher neutralizing antibody titers against the initial SARS-CoV-2 virus (wild type), as well as the Beta and Delta variants, when compared with the levels observed after the two-dose primary series. For more than 170 years, we have worked to make a difference for all who rely on us.

Vaccine 52

Vaccine Small Molecule Government Therapies 52

The Pharma Data

NOVEMBER 23, 2020

. Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine. AstraZeneca.

Vaccine 52

Vaccine Virus Trials Clinical Trials 52

The Pharma Data

AUGUST 10, 2020

The NHS test and trace system in England is cutting 6,000 staff by the end of August, the government has announced. The Department of Health has said that this is to provide a “more tailored approach” But critics will see it as the latest example of the government departing from its centralised approach to tackling the outbreak.

Government 52

Government Virus Trials Disease 52

The Pharma Data

AUGUST 18, 2020

REGN-COV2 could provide a much-needed treatment option for people already experiencing symptoms of COVID-19, and also has the potential to prevent infection in people exposed to the virus, thus slowing the spread of the global pandemic. and Roche will be responsible for distribution outside the U.S. “We

Clinical Trials 52

Clinical Trials Virus Trials Treatment 52

The Pharma Data

JANUARY 29, 2021

Pascal Soriot, Chief Executive Officer, said: “Today’s recommendation underscores the value of AstraZeneca’s COVID-19 vaccine which is not only effective and well-tolerated, but also easy to administer and, importantly, protects fully against severe disease and hospitalisations.

Vaccine 52

Vaccine Clinical Trials Virus Trials 52

The Pharma Data

JANUARY 29, 2021

Pascal Soriot, Chief Executive Officer, said: “Today’s approval underscores the value of AstraZeneca’s COVID-19 vaccine, which is not only effective and well tolerated, but also easy to administer and, importantly, protects fully against severe disease and hospitalisations.

Vaccine 52

Vaccine Clinical Trials Virus Trials 52

The Pharma Data

OCTOBER 30, 2020

About REGN-COV2 REGN-COV2 is a combination of two monoclonal antibodies (REGN10933 and REGN10987) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19. and Roche will develop, manufacture and distribute it outside the U.S.

Hospitals 52

Hospitals Virus Production Clinical Trials 52

The Pharma Data

AUGUST 6, 2020

The software will provide information about the prevalence of the disease in the local area to encourage people to be more cautious if levels rise. It does tell users to go into quarantine for 14 days if it determines there is a good chance they have been exposed to the virus. However, no formal decision has been made as yet. .

Virus 52

Virus Government Disease Production 52

The Pharma Data

APRIL 15, 2022

These data reinforce the potential function of a third dose of the vaccine in maintaining high levels of protection against the virus in this age group. The neutralizing GMT against the wild-type virus was 2153 (after three doses), compared to 335 after two doses. About BioNTech.

Immune Response 52

Immune Response Vaccine Clinical Trials Virus 52

The Pharma Data

NOVEMBER 9, 2020

Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the U.S. NVX-CoV2373 is a vaccine candidate engineered from the genetic sequence of SARS-CoV-2, the virus that causes COVID-19 disease. government. GAITHERSBURG, Md.,

Vaccine 52

Vaccine FDA Clinical Trials Immune Response 52

The Pharma Data

OCTOBER 18, 2020

Eurofins’ infectious disease centre for excellence, Viracor , developed the test based on its highly sensitive, FDA EUA-authorized SARS-CoV-2 RT-PCR assay. Available through the Eurofins direct-to-consumer company, empowerDX , the at home test can be ordered online ( [link] ) for $89. The Eurofins U.S.

Nurses 52

Nurses FDA Virus Government 52

The Pharma Data

DECEMBER 10, 2020

In the study, immunization with the hAd5-COVID-19 vaccine inhibited SARS-CoV-2 virus replication in 100% (10 of 10) of Rhesus macaques, with a drop in viral replication starting on the first day of vaccine administration, and undetectable viral levels as early as three to five days post-challenge in most of the animals.

Vaccine 52

Vaccine Immune Response Virus Clinical Trials 52

The Pharma Data

NOVEMBER 17, 2021

AstraZeneca continues to engage with governments, multilateral organisations and collaborators to ensure broad and equitable access to the vaccine. After vaccination, the surface spike protein is produced, priming the immune system to attack the SARS-CoV-2 virus if it later infects the body. 3,4,5,6,7).

Vaccine 52

Vaccine Clinical Trials Virus Licensing 52

The Pharma Data

SEPTEMBER 1, 2020

This can help healthcare professionals identify a SARS-CoV-2 infection in people suspected to carry the virus with results typically ready in 15 minutes. Roche is working closely with governments and health authorities around the world, and has significantly increased production to help ensure availability of tests globally.

Virus 52

Virus Laboratories Clinical Trials Treatment 52

Common Sense for Drug Policy Blog

JANUARY 1, 2024

Cost-Effectiveness of Syringe Service and Needle Exchange Programs "The infectious disease consequences of injection drug use place a heavy toll on entire communities and are a serious threat to the health and well-being of our nation. 19 In 2019, HIV care and treatment cost the US government more than $20 billion.

Virus 40

Virus Government Hospitals Treatment 40

The Pharma Data

NOVEMBER 10, 2020

We also observed that the antibody levels were higher after vaccination than those observed in convalescent sera from people who recovered from the disease,” said Nathalie Landry, Medicago’s executive vice president of scientific and medical affairs. microgram, 7.5-microgram microgram, 7.5-microgram

Immune Response 40

Immune Response Vaccine Clinical Trials Virus 40

DrugBank

JANUARY 29, 2025

Each of these mechanisms represents a distinct strategy to address the underlying genetic perturbations contributing to disease pathogenesis. In sickle cell disease, for instance, a missense mutation in the HBB gene , encoding the beta-globin subunit of hemoglobin, leads to the production of abnormal hemoglobin S.

Therapies 52

Therapies DNA RNA Disease 52

The Pharma Data

NOVEMBER 1, 2020

This is the first government contract in Europe for this test, which was CE marked to the IVD Directive (98/79/EC) in September. The BD Veritor Plus System is already in use across Europe to detect Influenza A+B, Respiratory Syncytial Virus (RSV), and Group A Strep. THE HAGUE, NETHERLANDS and FRANKLIN LAKES, N.J. , The first 1.2

Laboratories 52

Laboratories Virus FDA Government 52

The Pharma Data

MARCH 26, 2021

It comes at an important point in time, as governments now have more flexibility to move from inoculations in vaccination centers to a more decentralized vaccine roll-out through local doctors and general practitioners to accelerate our path out of the pandemic.”.

Vaccine 52

Vaccine Doctors Pharmacy FDA 52

The Pharma Data

DECEMBER 17, 2020

About casirivimab and imdevimab Casirivimab and imdevimab (formerly known as REGN-COV2 or REGEN-COV2) is a cocktail of two monoclonal antibodies (also known as REGN10933 and REGN10987, respectively) and was designed specifically to block infectivity of SARS-CoV-2, the virus that causes COVID-19. Have chronic kidney disease.

Hospitals 52

Hospitals Production Clinical Trials Virus 52

The Pharma Data

JANUARY 3, 2021

InspirMed is a newly established subsidiary of TLC specializing in the development of inhalable liposome formulation programs, such as TLC19 for the treatment of Coronavirus disease 2019 (COVID-19) as well as other programs for severe acute and chronic pulmonary diseases. Cautionary Note on Forward-Looking Statements.

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Disease 52

The Pharma Data

JANUARY 22, 2021

Patrick Soon-Shiong MD, chairman and CEO of ImmunityBio, said: “There is an urgent need for a vaccine that not only offers immediate protection but also activates T cells to clear the virus. When multiple mutations occur at the receptor-binding domain of the spike protein, it renders antibodies ineffective.

Vaccine 52

Vaccine Immune Response Government RNA 52

The Pharma Data

DECEMBER 14, 2020

government’s Operation Warp Speed, Moderna has been working with the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID). government provided almost $1 billion for research and other preparations while agreeing to acquire 200 million doses for about $3.1 billion worth of vaccines.

Vaccine 52

Vaccine FDA Virus Government 52

The Pharma Data

AUGUST 21, 2020

Bill Anderson, chief executive officer of Roche Pharmaceuticals, said: “We are excited about the potential for one medicine to serve both as a treatment for those infected as well as protection for people exposed to the virus. REGN -COV2 could be a critical line of defense against the Covid-19 pandemic.”.

Vaccine 52

Vaccine Clinical Trials Pharmacy Virus 52